Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of MK-7240 in Healthy Participants (MK-7240-009)
Sponsor: Merck Sharp & Dohme LLC
Summary
The goal of this study is to learn what happens to MK-7240 in a healthy person's body over time (pharmacokinetic or PK study). Researchers also want to learn about the safety of MK-7240 and if people tolerate it.
Official title: A Randomized, Open-label, Parallel-group Study to Assess the Pharmacokinetic Bioequivalence of Subcutaneously-administered Tulisokibart Delivered by 2 Different Autoinjectors in Healthy Participants
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
330
Start Date
2026-03-05
Completion Date
2026-09-03
Last Updated
2026-04-08
Healthy Volunteers
Yes
Conditions
Interventions
Tulisokibart Form 1
Solution for injection.
Tulisokibart Form 2
Solution for injection.
Locations (2)
Nucleus Network ( Site 0002)
Brisbane, Queensland, Australia
Nucleus Network ( Site 0001)
Melbourne, Victoria, Australia